SEC Company Response from AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Mar 16, 2009
AGENUS INC (AGEN) (CIK 0001098972)
Date: March 16, 2009 · CIK: 0001098972 · Accession: 0001193125-09-055424
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-149116, 333-150326, 333-156556
Letter
VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission Re: Antigenics Inc. Registration Statement on Form S-1, filed on January 2, 2009, as amended on January 27, 2009 and March 16, 2009 (File No. 333-156556) Post-Effective Amendment on Form S-1 to the Registration Statement on Form S-3, filed on January 2, 2009, as amended on March 16, 2009 (File No. 333-149116) Post-Effective Amendment on Form S-1 to the Registration Statement on Form S-3, filed on January 2, 2009, as amended on March 16, 2009 (File No. 333-150326)
Dear Mr. Pitko,
In connection with the above referenced registration statement and post-effective amendments (collectively, the “Registration Statements”), Antigenics Inc. (the “Company”) hereby acknowledges that (i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filings effective, it does not foreclose the Commission from taking any action with respect to the filings, (ii) the action of the Commission or the staff pursuant to delegated authority, in declaring the filings effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filings, and (iii) the Company may not assert the declaration of effectiveness as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
The Company requests effectiveness of each Registration Statement at 9:00 AM on March 18, 2009, or as soon thereafter as practicable.
Please call the undersigned at (781) 674-4400 as soon as the Registration Statements have been declared effective.
Best regards,
/s/ Karen Higgins
Valentine
Show Raw Text
CORRESP 1 filename1.htm SEC Letter March 16, 2009 VIA EDGAR Mr. Bryan Pitko Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-0306 Re: Antigenics Inc. Registration Statement on Form S-1, filed on January 2, 2009, as amended on January 27, 2009 and March 16, 2009 (File No. 333-156556) Post-Effective Amendment on Form S-1 to the Registration Statement on Form S-3, filed on January 2, 2009, as amended on March 16, 2009 (File No. 333-149116) Post-Effective Amendment on Form S-1 to the Registration Statement on Form S-3, filed on January 2, 2009, as amended on March 16, 2009 (File No. 333-150326) Dear Mr. Pitko, In connection with the above referenced registration statement and post-effective amendments (collectively, the “Registration Statements”), Antigenics Inc. (the “Company”) hereby acknowledges that (i) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filings effective, it does not foreclose the Commission from taking any action with respect to the filings, (ii) the action of the Commission or the staff pursuant to delegated authority, in declaring the filings effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filings, and (iii) the Company may not assert the declaration of effectiveness as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. The Company requests effectiveness of each Registration Statement at 9:00 AM on March 18, 2009, or as soon thereafter as practicable. Please call the undersigned at (781) 674-4400 as soon as the Registration Statements have been declared effective. Best regards, /s/ Karen Higgins Valentine Karen Higgins Valentine Vice President and General Counsel Cc: Garo Armen, Chairman and CEO Paul Kinsella, Ropes & Gray LLP